Abstract
Correction to “R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation”
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have